Attila Lehotzky

Dr. Attila Lehotzky

Institute of Enzymology, Research Centre for Natural Sciences

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
TRTobias Rumpf
Tobias Rumpf
MSMatthias Schiedel
Matthias Schiedel
BMBerin Karaman Mayack
Berin Karaman Mayack
CRClaudia Roessler
Claudia Roessler
BNBrian J. North
Brian J. North
MJManfred Jung
Manfred Jung
Sirtuins are a highly conserved class of NAD+-dependent lysine deacylases. The human isotype Sirt2 has been implicated in the pathogenesis of cancer, inflammation and neurodegeneration, which makes the modulation of Sirt2 activity a promising strategy for pharmaceutical intervention. A rational basis for the development of optimized Sirt2 inhibitors is lacking so far. Here we present high-resolution structures of human Sirt2 in complex with highly selective drug-like inhibitors that show a unique inhibitory mechanism. Potency and the unprecedented Sirt2 selectivity are based on a ligand-induced structural rearrangement of the active site unveiling a yet-unexploited binding pocket. Application of the most potent Sirtuin-rearranging ligand, termed SirReal2, leads to tubulin hyperacetylation in HeLa cells and induces destabilization of the checkpoint protein BubR1, consistent with Sirt2 inhibition in vivo. Our structural insights into this unique mechanism of selective sirtuin inhibition provide the basis for further inhibitor development and selective tools for sirtuin biology.

1 November 2004 in Neurobiology of Disease
Verified
Journal Article
Closed access
Gabor G. KovacsGabor G. Kovacs
Gabor G. Kovacs
LLLajos László
Lajos László
JKJános Kovács
János Kovács
PJPoul Henning Jensen
Poul Henning Jensen
ELEvo Lindersson
Evo Lindersson
JOJudit Ovádi
Judit Ovádi

15 July 2009 in Glia
Verified
Journal Article
Closed access
PDF file
ALAttila Lehotzky
Attila Lehotzky
PLPierre Lau
Pierre Lau
NTNatália Tőkési
Natália Tőkési
NMNaser Muja
Naser Muja
LHLynn D. Hudson
Lynn D. Hudson
JOJudit Ovádi
Judit Ovádi

1 June 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
NTNatália Tőkési
Natália Tőkési
ALAttila Lehotzky
Attila Lehotzky
IHIstvan Horvath
Istvan Horvath
BSBálint Szabó
Bálint Szabó
JOJudit Oláh
Judit Oláh
JOJudit Ovádi
Judit Ovádi
TPPP/p25 (tubulin polymerization-promoting protein/p25) is an unstructured protein that induces microtubule polymerization in vitro and is aligned along the microtubule network in transfected mammalian cells. In normal human brain, TPPP/p25 is expressed predominantly in oligodendrocytes, where its expression is proved to be crucial for their differentiation process. Here we demonstrated that the expression of TPPP/p25 in HeLa cells, in doxycycline-inducible CHO10 cells, and in the oligodendrocyte CG-4 cells promoted the acetylation of alpha-tubulin at residue Lys-40, whereas its down-regulation by specific small interfering RNA in CG-4 cells or by the withdrawal of doxycycline from CHO10 cells decreased the acetylation level of alpha-tubulin. Our results indicate that TPPP/p25 binds to HDAC6 (histone deacetylase 6), an enzyme responsible for tubulin deacetylation. Moreover, we demonstrated that the direct interaction of these two proteins resulted in the inhibition of the deacetylase activity of HDAC6. The measurement of HDAC6 activity showed that TPPP/p25 is able to induce almost complete (90%) inhibition at 3 microM concentration. In addition, treatment of the cells with nocodazole, vinblastine, or cold exposure revealed that microtubule acetylation induced by trichostatin A, a well known HDAC6 inhibitor, does not cause microtubule stabilization. In contrast, the microtubule bundling activity of TPPP/p25 was able to protect the microtubules from depolymerization. Finally, we demonstrated that, similarly to other HDAC6 inhibitors, TPPP/p25 influences the microtubule dynamics by decreasing the growth velocity of the microtubule plus ends and also affects cell motility as demonstrated by time lapse video experiments. Thus, we suggest that TPPP/p25 is a multiple effector of the microtubule organization.

7 January 2016 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MSMatthias Schiedel
Matthias Schiedel
TRTobias Rumpf
Tobias Rumpf
BMBerin Karaman Mayack
Berin Karaman Mayack
ALAttila Lehotzky
Attila Lehotzky
JOJudit Oláh
Judit Oláh
MJManfred Jung
Manfred Jung

1 November 2006 in Biochemistry
Verified
Journal Article
Closed access
OVOrsolya Vincze
Orsolya Vincze
NTNatália Tökési
Natália Tökési
JOJudit Oláh
Judit Oláh
EHEmma Hlavanda
Emma Hlavanda
ÁZÁgnes Zotter
Ágnes Zotter
JOJudit Ovádi
Judit Ovádi